Alzheimer's Disease

What is Alzheimer's Disease?

Alzheimer's disease is a progressive neurological disorder that causes brain cells to degenerate and die. It is the most common cause of dementia, leading to a continuous decline in cognitive, behavioral, and social skills, which affects a person's ability to function independently.

Symptoms of Alzheimer's Disease

• Memory loss: One of the earliest and most common signs, especially forgetting recently learned information.
• Difficulty in planning or solving problems: Trouble following familiar recipes or managing bills.
• Confusion with time or place: Losing track of dates, seasons, or the passage of time.
• Challenges understanding visual images and spatial relationships: Issues with reading, judging distance, or recognizing objects.
• Problems with speaking or writing: Struggling with vocabulary, stopping in the middle of a conversation, or repeating oneself.
• Misplacing items and being unable to retrace steps to find them.
• Poor judgment: Decreased judgment or decision-making skills.
• Withdrawal from social activities: Avoiding social interactions or hobbies.
• Changes in mood or personality: Increased confusion, suspicion, depression, or anxiety.

Risk Factors

• Age: The most significant known risk factor. Most people with Alzheimer's are 65 and older.
• Family history and genetics: Having a parent or sibling with Alzheimer's increases the risk.
• Genetic predisposition: Specific genes, such as APOE-e4, are linked to a higher risk.
• Head injuries: Past head trauma may increase the risk.
• Lifestyle and heart health: Factors like smoking, obesity, high blood pressure, and diabetes can elevate the risk.

Stages of Alzheimer's Disease

1. Early Stage (Mild Alzheimer's)

• Symptoms: Minor memory lapses and difficulty with complex tasks.
• Independence: Individuals may still function independently but with occasional assistance.

2. Middle Stage (Moderate Alzheimer's)

• Symptoms: More pronounced memory loss, confusion, and difficulty recognizing family and friends.
• Behavioral changes: Increased wandering, agitation, and repetitive behaviors.
• Assistance: Requires more significant support with daily activities.

3. Late Stage (Severe Alzheimer's)

• Symptoms: Severe memory loss, loss of communication abilities, and complete dependence on caregivers.
• Physical symptoms: Difficulty walking, swallowing, and general unresponsiveness.

Diagnosis

• Medical history: Reviewing medical and family history, along with changes in behavior.
• Cognitive tests: Assessing memory, problem-solving, attention, and language skills.
• Neurological exams: Evaluate balance, reflexes, and senses.
• Brain imaging: CT or MRI scans to rule out other conditions and identify brain atrophy.
• Biomarker tests: Can include spinal fluid tests or PET scans to detect specific protein changes associated with Alzheimer's.

Management and Treatment

• Medications:
  • Cholinesterase inhibitors: Helps increase communication between brain cells (e.g., donepezil, rivastigmine).
  • Memantine: Regulates brain chemicals and may help with memory and learning.
  • Medications for symptoms: To manage depression, anxiety, or behavioral issues.
• Therapies:
  • Occupational therapy: Helps adapt living environments for safety.
  • Cognitive stimulation: Engages memory and thinking skills through activities.
• Lifestyle modifications: Regular physical activity, a balanced diet, social engagement, and mental stimulation.

Complications of Alzheimer's Disease

• Inability to communicate: Leads to increased frustration and behavioral challenges.
• Reduced mobility: Can lead to bedsores, blood clots, and infections.
• Malnutrition and dehydration: Challenges with swallowing or forgetting to eat/drink.
• Increased risk of infections: Such as pneumonia due to weakened immune function.
• Death: Alzheimer's is a terminal disease, with most people succumbing to complications such as infections or organ failure.

References & Research

Historical Background

Alzheimer's disease was first described in 1906 by German psychiatrist and neuropathologist Alois Alzheimer, who identified the characteristic amyloid plaques and neurofibrillary tangles in the brain of a patient named Auguste Deter. The disease was formally named after him by Emil Kraepelin in 1910.

Key Research Papers

1. Scheltens P, De Strooper B, Kivipelto M, et al. Alzheimer's disease. The Lancet. 2021;397(10284):1577-1590.
2. Jack CR Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):257-262.
3. Sevigny J, Chiao P, Bussiere T, et al. The antibody aducanumab reduces amyloid-beta plaques in Alzheimer's disease. Nature. 2016;537(7618):50-56.
4. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in early Alzheimer's disease (Clarity AD). N Engl J Med. 2023;388(1):9-21.
5. Sims JR, Zimmer JA, Evans CD, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512-527.
6. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353-356.
7. Jansen IE, Savage JE, Watanabe K, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019;51(3):404-413.
8. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020;396(10248):413-446.
9. Cummings JL, Morstorf T, Zhong K. Alzheimer's disease drug-development pipeline: few candidates, frequent failures. Alzheimers Res Ther. 2014;6(4):37.
10. Masters CL, Bateman R, Blennow K, et al. Alzheimer's disease. Nat Rev Dis Primers. 2015;1:15056.
11. 2021 Alzheimer's disease facts and figures. Alzheimers Dement. 2021;17(3):327-406.
12. Tanzi RE. The genetics of Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(10):a006296.

Back to Table of Contents